Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point - 16/04/14

M. Sapoval ^{a, c, ⁎} , M. Azizi ^{a, b}

^a Université Paris Descartes, 75006 Paris, France 

^b Hôpital européen Georges-Pompidou, AHT Unit, AP–HP, 20, rue Leblanc, 75015 Paris cedex 15, France 

^c Vascular and Oncological Interventional Radiology department, Hôpital européen Georges Pompidou, 20, rue Leblanc, 75015 Paris cedex 15, France 

^⁎Corresponding author.

Le texte complet de cet article est disponible en PDF.